Back to Journals » Vascular Health and Risk Management » Call For Papers

Vascular Health and Risk Management


The following Article Collection/ Thematic Series is currently open for submissions:

Cardio-Ankle Vascular Index

Dove Medical Press is pleased to invite you to submit your work to an upcoming Thematic Series on “Cardio-Ankle Vascular Index” guest edited by Dr. Kohji Shirai in Vascular Health and Risk Management.

When submitting your work, please use the promo code ZLHAK to indicate that your manuscript should be considered for the Thematic Series on “Cardio-Ankle Vascular Index”. This code will also provide you with a 20% discount on the advertised article processing charge. The deadline for submission of manuscripts is October 1st, 2022.

For any enquiries, please email to Jenni Shackleton, Commissioning Editor, at [email protected]

About the Thematic Series

The cardio-ankle vascular index (CAVI) is a new index of the overall stiffness of the artery from the origin of the aorta to the ankle. CAVI is a key tool for the improvement of preventative medicine as this index can estimate the risk of atherosclerosis.

A significant feature of CAVI is that it is entirely independent of blood pressure at the time of measurement. CAVI has been proven to be negatively influenced by many arteriosclerotic diseases, such as coronary artery disease, carotid arteriosclerosis, chronic kidney disease and cerebrovascular disease and many coronary risk factors, such as hypertension, diabetes mellitus, dyslipidemia and smoking. Conversely, CAVI can be positively influenced by lifestyle modifications such as smoking cessation.

Recently, it has been reported that CAVI and several left ventricular functions are co-related, suggesting a connection between the heart muscle and vascular function.

This special CAVI issue of Vascular Health and Risk Management serves to highlight the current and future potential of this index.

View all papers in this thematic series


Call For Papers

Editor-in-Chief: Professor Roland Asmar

To see where Vascular Health and Risk Management is indexed online view the Journal Metrics

What is the advantage to you of publishing in Vascular Health and Risk Management?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although Vascular Health and Risk Management receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Vascular Health and Risk Management has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution a publication processing fee.

PubMed Central and MedLine
Vascular Health and Risk Management is indexed on PubMed Central and MedLine (title abbreviation: Vasc Health Risk Manag). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so.  Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page, you'll just need to supply the working title of your next paper and when you intend to submit by.

Yours sincerely
Professor Roland Asmar
Editor-in-Chief
Vascular Health and Risk Management

Email: Editor-in-Chief